RT Journal Article
T1 SEOM-TTCC clinical guideline in nasopharynx cancer (2021).
A1 Rueda-Dominguez, Antonio
A1 Cirauqui, Beatriz
A1 Garcia-Castaño, Almudena
A1 Alvarez-Cabellos, Ruth
A1 Carral-Maseda, Alberto
A1 Castelo-Fernandez, Beatriz
A1 Iglesias-Rey, Leticia
A1 Rubio-Casadevall, Jordi
A1 Arrazubi, Virginia
A1 Mesia, Ricard
K1 Clinical Practice Guidelines
K1 Diagnosis
K1 Follow-up
K1 Nasopharyngeal cancer
K1 Treatment
AB Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiotherapy (RT) is the cornerstone of locoregional treatment of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
PB Springer
YR 2022
FD 2022-03-18
LK http://hdl.handle.net/10668/21108
UL http://hdl.handle.net/10668/21108
LA en
NO Rueda Domínguez A, Cirauqui B, García Castaño A, Alvarez Cabellos R, Carral Maseda A, Castelo Fernández B, et al. SEOM-TTCC clinical guideline in nasopharynx cancer (2021). Clin Transl Oncol. 2022 Apr;24(4):670-680
DS RISalud
RD Sep 13, 2025